In the past decade, the world confronted several pandemics of emerging infectious diseases including Zika virus and most recently Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). One of ...

On the basis of the clinical and laboratory findings, the child was diagnosed as having Guillain-Barré syndrome. Supportive treatment included mechanical ventilation, nasogastric tube feeding ...

--Hansa Biopharma AB, "Hansa" today announced that it will host a virtual investor event on Guillain-Barré syndrome on Monday, June 16, 2025 at 14:00 CEST/ 8:00 AM EDT. David R. Cornblath, MD ...

Guillain-Barré syndrome is a rare but serious neurological condition that can cause progressive limb weakness and eventual paralysis, with an annual incidence of one to four cases per 100,000 people ...

More information: Sharifa Nasreen et al, Risk of Guillain-Barré syndrome after COVID-19 vaccination or SARS-CoV-2 infection: A multinational self-controlled case series study, Vaccine (2025).